JPX : 4548.T

Seikagaku Corporation

$730 JPY

-$16 (-2.14%)

Volume
149.3K
Average Volume
137.79K
Market Capitalization
$39.86B
P/E Ratio
27.06
Dividend Yield
4.11%
Price Target
Year High
$820.00
Year Low
$632.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.34
Company Overview

JPX

Kenji Mizutani

Medical - Devices

Healthcare

4548.T

1142

JP

JPY

https://www.seikagaku.co.jp

81 3 5220 8950

N/A

N/A

Liquidity Metrics

0.00

5.34

3.86

1.18

0.00

Sales & Valuation

$36.64B

1.09

0.53

0.00

0.00

Profitability

$26.98

$1.47B

4.02%

4.12%

2.02%

1.71%

P/E Metrics

27.06

-0.09

-0.09

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

4.03

4/9

$32.98B

$86.34B

$11.04B

$1.38B

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Ryoji Tomokiyo Executive Vice President of Business Development & Marketing
Kazushi Takeda Senior Executive Officer, Executive Vice President of F&A and Corporate Staff
Masayuki Ito Executive Vice President & Head of Production
Kenji Mizutani President, Chief Executive Officer & Representative Director
Toshiyuki Okada Managing Executive Officer & Director
Yosuke Funakoshi Senior Executive Officer, GM of Research & Development and Director
Yuji Shimojima Executive Vice President of Overseas Subsidiaries & Medical Science
Poll Results

No votes yet today — be the first to share your view!

About Seikagaku Corporation (JPX:4548.T) Stock

Headquartered in Tokyo, Japan, Seikagaku Corporation, established in 1947, specializes in the global development, manufacturing, and distribution of pharmaceuticals and medical devices, with a core focus on glycoconjugates. The company, which was formerly known as K.K. Seikagaku Kenkyusho until its name change in 1962, operates through two primary segments: Pharmaceuticals and LAL. Its product portfolio encompasses a range of therapeutic and surgical solutions. For joint health, Seikagaku provides intra-articular injections like ARTZ, ARTZ Dispo, VISCO-3, and SUPARTZ FX, designed to enhance joint function. The company also supplies ophthalmic surgical aids such as OPEGAN, OPEGAN Hi, and SHELLGAN, alongside MucoUp for endoscopic mucosal resection. Other notable offerings include Gel-One, a ... cross-linked hyaluronate hydrogel addressing knee osteoarthritis, and HERNICORE for lumbar disc herniation. Beyond finished products, Seikagaku is a supplier of bulk materials, specifically sodium hyaluronate and sodium chondroitin sulfate, which find application in various pharmaceutical and cosmetic formulations. Furthermore, the company develops and markets specialized endotoxin-detecting reagents, including Pyrochrome, ENDOSPECY, and TOXICOLOR, which are crucial for quality assurance in injectable pharmaceuticals, biological products, medical devices, manufacturing operations, and dialysate water quality. Its offerings also extend to oral care, featuring the KINUSUI Spray mouthwash. Seikagaku maintains a robust development pipeline, with promising candidates such as SI-6603 for lumbar disc herniation, SI-614 (a modified hyaluronate for dry eyes), SI-613 for osteoarthritis, SI-613-ETP targeting enthesopathy, and SI-449, a powdered adhesion barrier.

Frequently Asked Questions

What is the current Seikagaku Corporation (4548.T) stock price?

Seikagaku Corporation(JPX:4548.T) stock price is $730 in the last trading session. During the trading session, 4548.T stock reached the peak price of $820 while $632 was the lowest point it dropped to. The percentage change in 4548.T stock occurred in the recent session was --2.14% while the dollar amount for the price change in 4548.T stock was -$16.

4548.T's industry and sector of operation?

The JPX listed 4548.T is part of Medical - Devices industry that operates in the broader Healthcare sector.

Who are the executives of 4548.T?

Ryoji Tomokiyo | Executive Vice President of Business Development & Marketing
Kazushi Takeda | Senior Executive Officer, Executive Vice President of F&A and Corporate Staff
Masayuki Ito | Executive Vice President & Head of Production
Kenji Mizutani | President, Chief Executive Officer & Representative Director
Toshiyuki Okada | Managing Executive Officer & Director

How many employees does 4548.T have?

Number of 4548.T employees currently stands at 1142. 4548.T operates from Marunouchi Center Building, Tokyo, TY 100-0005, JP.

Link for 4548.T official website?

Official Website of 4548.T is: https://www.seikagaku.co.jp

How do I contact 4548.T?

4548.T could be contacted at phone #81 3 5220 8950 and can also be accessed through its website. 4548.T operates from Marunouchi Center Building, Tokyo, TY 100-0005, JP.

How many shares of 4548.T are traded daily?

The average number of 4548.T shares traded daily for last 3 months was 137.79K.

What is the market cap of 4548.T currently?

The market value of 4548.T currently stands at $39.86B with its latest stock price at $730